EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes

Allison Mo iD, Erica Wood, Jake Shortt iD, Erin Hu, Zoe McQuilten iD

European Journal of Haematology · 2023

DOI: 10.1111/ejh.14049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2023. Verfasst von Allison Mo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Transfusion Research Unit, School of Public Health & Preventive Medicine, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Thrombocytopenia, Tranexamic Acid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Haematology Society of Australia and New Zealand, Monash University, National Blood Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to describe the burden of thrombocytopenia, supportive care practices, bleeding complications and predictors of bleeding in MDS patients within a large Australian hospital network, to better understand the use and effectiveness of platelet transfusions in MDS.

Methods

A retrospective cohort study of patients aged ≥18 years with MDS, chronic myelomonocytic leukaemia or MDS/myeloproliferative overlap neoplasm admitted from 2016 to 2018 was conducted. Data were obtained from hospital medical records.

Results

One hundred seventy‐nine patients (median age 78 years, 61.5% male) were identified. The median platelet count at first admission was 90 × 10 9 /L. Twenty‐eight (15.6%) patients had severe thrombocytopenia (platelet count

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelodysplastic SyndromesThrombocytopeniaTranexamic AcidHumansMaleAdolescentAdultAgedFemalePlatelet TransfusionRetrospective StudiesAustraliaHemorrhage

Stichwörter der Autor:innen

haemorrhagemyelodysplastic syndromesplatelet transfusionthrombocytopenia

Substanzen

Tranexamic Acid

Autor:innen und Institutionen

  • Transfusion Research Unit, School of Public Health & Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Monash Haematology, Monash Health, Melbourne, Victoria, Australia.
  • Austin Pathology and Department of Haematology, Austin Health, Melbourne, Victoria, Australia.
  • School of Clinical Sciences, Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia.
  • Pharmacy Department, Monash Health, Melbourne, Victoria, Australia.

ORCID-Profile: Allison Mo, Jake Shortt, Zoe McQuilten

Förderung

  • Haematology Society of Australia and New Zealand
  • Monash University
  • National Blood Authority
  • National Health and Medical Research Council
  • Australian NHMRC Emerging Leadership Fellowships
  • NHMRC Leadership Fellowship

Zitieren

APA

Mo, A., Wood, E., Shortt, J., Hu, E., & McQuilten, Z. (2023). Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes. European Journal of Haematology. https://doi.org/10.1111/ejh.14049

Vancouver

Mo A, Wood E, Shortt J, Hu E, McQuilten Z. Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes. European Journal of Haematology. 2023. doi:10.1111/ejh.14049

BibTeX
@article{Mo2023,
  author = {Mo, Allison and Wood, Erica and Shortt, Jake and Hu, Erin and McQuilten, Zoe},
  title = {Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes},
  journal = {European Journal of Haematology},
  year = {2023},
  doi = {10.1111/ejh.14049}
}
Kostenlos starten →